BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 10702792)

  • 1. NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis.
    Jo H; Zhang R; Zhang H; McKinsey TA; Shao J; Beauchamp RD; Ballard DW; Liang P
    Oncogene; 2000 Feb; 19(7):841-9. PubMed ID: 10702792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
    Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation.
    Hanson JL; Hawke NA; Kashatus D; Baldwin AS
    Cancer Res; 2004 Oct; 64(20):7248-55. PubMed ID: 15492243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.
    Huber MA; Azoitei N; Baumann B; GrĂ¼nert S; Sommer A; Pehamberger H; Kraut N; Beug H; Wirth T
    J Clin Invest; 2004 Aug; 114(4):569-81. PubMed ID: 15314694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells.
    Cheng G; Meinkoth JL
    Oncogene; 2001 Nov; 20(50):7334-41. PubMed ID: 11704863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function.
    Wang Y; Cui H; Schroering A; Ding JL; Lane WS; McGill G; Fisher DE; Ding HF
    Nat Cell Biol; 2002 Nov; 4(11):888-93. PubMed ID: 12389034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
    Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
    Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
    Du J; Jiang B; Coffey RJ; Barnard J
    Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transcription factor NF-kappa B/RelA are constitutively activated and localized in the cell nuclei of E1A + cHa-Ras transformants].
    Darieva ZA; Pospelov VA; Pospelova TV
    Tsitologiia; 1999; 41(7):622-7. PubMed ID: 10496024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
    Fenton RG; Hixon JA; Wright PW; Brooks AD; Sayers TJ
    Cancer Res; 1998 Aug; 58(15):3391-400. PubMed ID: 9699671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NF-kappaB inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells.
    Kwon O; Kim KA; Kim SO; Ha R; Oh WK; Kim MS; Kim HS; Kim GD; Kim JW; Jung M; Kim CH; Ahn JS; Kim BY
    Carcinogenesis; 2006 Nov; 27(11):2258-68. PubMed ID: 16774937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis.
    Duran A; Linares JF; Galvez AS; Wikenheiser K; Flores JM; Diaz-Meco MT; Moscat J
    Cancer Cell; 2008 Apr; 13(4):343-54. PubMed ID: 18394557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras oncogene transformation of human B lymphoblasts is associated with lymphocyte activation and with a block of differentiation.
    Sirinian MI; Marchetti A; Di Rocco G; Starace G; Jucker R; Nasi S
    Oncogene; 1993 Jan; 8(1):157-63. PubMed ID: 8423993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells.
    Takahashi M; Mutoh M; Shoji Y; Kamanaka Y; Naka M; Maruyama T; Sugimura T; Wakabayashi K
    Oncogene; 2003 Oct; 22(48):7667-76. PubMed ID: 14576830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells.
    Shao J; Sheng H; DuBois RN
    Cancer Res; 2002 Jun; 62(11):3282-8. PubMed ID: 12036946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
    Tokumitsu Y; Nakano S; Ueno H; Niho Y
    J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of PKC zeta in NIH3T3 cells does not induce cell transformation nor tumorigenicity and does not alter NF kappa B activity.
    Montaner S; Ramos A; Perona R; Esteve P; Carnero A; Lacal JC
    Oncogene; 1995 Jun; 10(11):2213-20. PubMed ID: 7784066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.